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Abstract 
In a mammal, at the beginning of its development, the gonad is bipotential. The shift into a 
male or female pathway is coordinated by the sex chromosomal complement, which triggers 
a series of genetic pathways signaling the developmental pattern of the gonadal anlage. 
Being mutually exclusive, the differentiated gonad should be either a testis or an ovary. In 
females, the absence of SRY, a testis-determining gene, drives the signaling cascades 
controlling the ovarian differentiation.  
Albeit rare, disorders of the gonadal differentiation may occur in men and domestic animals 
and may cause infertility or sterility. In dogs, the XX;SRY-negative disorder of sexual 
development (DSD) is the most frequent condition. The disorder typically presents a wide 
spectrum of developmental conditions of the gonad and variable virilization of the genital 
phenotype, that may be accompanied by hypospadias. This condition may be inherited as a 
sex–limited autosomal recessive trait; however, the mechanism explaining its occurrence 
remains poorly understood. This review intends to present an overview of the morphologic 
features of XX;SRY-negative syndrome in dogs, while addressing the current knowledge 
regarding the genetic mechanism underlying this condition. 
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1. The XX;SRY-Negative DSD Condition in Dogs 
Even though Disorders of Sex Development (DSD) are rare genetic conditions in dogs, the most 
common in occurrence is the testicular (T-DSD) or ovotesticular (OT-DSD) disorder, presenting a 
female karyotype and a lack of the SRY (sex-determining region Y) gene (78,XX;SRY-negative DSD) 
[1]. Dogs are the domestic species presenting the XX female-to-male sex reversal condition most 
[2], with sporadic descriptions appearing in horses [3, 4], cats [5] and pigs [6]. 
In an older nomenclature, this condition was categorized as intersex, under the XX true 
hermaphroditism or the XX sex reversal (or XX male syndrome) conditions [7]. This disorder is 
characterized by a wide spectrum of developmental conditions of the gonad, co-existing with 
variable virilization of the genital phenotype [8, 9]. The higher prevalence of XX;SRY-negative DSD 
in particular breeds (e.g., the English and the American Cocker Spaniel, the Beagle or the Pug) and 
genetic lines [7, 10, 11], sustains the hypothesis that this condition may be inherited as a sex–
limited autosomal recessive trait [1, 8]. 
In normal dogs, as in other placental mammals, the sexual development comprises three 
sequential steps; namely the definition of the sex chromosome complement at fertilization, the 
differentiation of the gonads as testis or ovary (gonadal sex), and the differentiation of the tubular 
and phenotypic sex, determined from the gonadal sex [2]. In males, testis differentiation is 
triggered by the expression of SRY that generates a cascade of molecular events that coordinate 
the differentiation of the urogenital tract into a male pattern. In the female embryo, 
differentiation proceeds in the absence of SRY expression, leading to the activation of a non-
masculinizing cascade of events directing the development of the embryo reproductive tract 
according to the female pattern [12]. In mammals, in the normal reproductive tract differentiation, 
male and female patterns are mutually exclusive. 
The process of sexual differentiation is rather complex and so finely tuned that a minimal 
alteration, whether in the activation of the genes involved in the gonadal sex differentiation or in 
the functioning of downstream molecular pathways, may originate severe DSD disorders. This 
review focuses on the morphological characterization of the XX;SRY-negative syndrome in dogs 
and addresses the current state of understanding of the genetic mechanism underlying this 
condition. 
1.1 The Phenotype of XX;SRY-Negative Dogs 
The phenotype of naturally occurring conditions in dogs remarkably resembles that of the XX 
DSD ovotesticular or testicular subtype in humans [13]. Affected dogs may present either ovotestis 
or testicles [14]. Table 1 summarizes the information gathered from available publications on  
XX;SRY-negative conditions in dogs whose diagnoses were supported by the karyotype and 
cytogenetic analyses establishing the absence of SRY. Even though in most cases a female 
OBM Genetics 2019; 3(2), doi:10.21926/obm.genet.1902074 
 
Page 3/21 
phenotype prevailed, with animals showing an enlarged clitoris with internal baculum exposed 
from the vulva, on what concerns the gonad development the prevalent morphology was the 
testicular (Table 1). 
Albeit most affected dogs present either bilateral testes or ovotestis [8], a combination of a 
testicular gonad on one side and an ovotestis in the other may sporadically be found (Table 1). 
This seems to contrast the report by Meyers-Wallen, that describes a smaller prevalence of 
bilateral testis in American Cocker dogs suffering from XX-DSD. Due to the small number of cases 
diagnosed within each breed, testing to discern if these differences could be explained by the 
genetic background of the individuals is not allowed. 
In both the testicular and the ovotesticular sub-types, the gonads are generally found in an 
intra-abdominal position, and animals are diagnosed as cryptorchid. Since some development of 
the Wolffian derivates occur, the epididymides are found, as well as a partially underdeveloped 
vas deferens, which runs parallel to the walls of a hypoplastic uterus [8, 31]. These animals usually 
present Wolffian duct derivates, like the epididymides, and a more or less rudimentary vas 
deferens [8, 15, 17, 23], along with persistence of a uterus. Albeit the existence of a prostate has 
been described in some cases [32, 33], in my professional practice the prostate was never located 
by digital palpation, visualized during surgery, nor reported by any other authors [8, 16]. 
In general, ovotestis in 78,XX;SRY-negative dogs are involved by the ovarian bursa (Figure 1A), 
like the ovaries in normally developed females [31]. Although small fragments of ovarian tissue 
containing a few, sporadic follicles often showing degenerative changes may be found in cortical 
position (Figure 2), the ovarian differentiation is usually compromised. Also, these small patches of 
ovarian tissue are limited to some areas of the gonadal cortex, for which multiple non-continuous 
sections of the gonad are needed to establish a sound histological diagnosis of ovotestis. In some 
cases, the existence of antral follicles or corpora lutea have been described [22], as well as the 
existence of ovarian cycles [8, 23]. However, according to available reports, most XX;SRY-negative 
dogs never experienced estrus [9, 25].  
The testicular pattern is not entirely obtained either. Albeit formation of testicular lobules 
occurs, usually the mediastinum testis is not found in these animals (Figure 1B), whether in 
ovotestis or in testicle-like gonads, which may make it difficult to discern the abdominal location 
of the gonad during an ultrasonographic examination [31]. XX;SRY-negative dogs frequently 
present both oviducts and epididymis (Figure 1), mainly when ovotestis are present; all animals 
present an underdeveloped uterus. Often, a rudimentary or hypoplastic vas deferens can be seen 
running parallel or inserted in the wall of uterine horns [8, 31]. 
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Table 1 Reported cases of 78,XX;SRY-negative dogs supported by karyotype and cytogenetic analysis. 
Phenotype 
scored at 
birth 
n Breed 
Type of gonads  
[Test/Ovot/Ov] 
Position 
[ABD/ING
/SCr] 
External morphology Internal morphology Comments References 
Male 1 French Bulldog Bilateral Test  ABD 
Hypoplastic penis 
Preputium caudally dislocated  
Cryptorchidism 
Absent scrotum 
Epididymides  
Oviducts not found 
Uterus 
- [15] 
Male 1 Pug Bilateral Test 
SC-ING 
[left] 
ABD 
[right] 
Hypoplastic penis 
Preputium caudally dislocated  
Cryptorchidism 
Absent scrotum 
Uterus - [16] 
Female 1 French Bulldog Bilateral Test ING 
Vulva in ventral position 
Enlarged clitoris with bone 
Atresia of the cranial vagina 
No other information  
- 
[17] 
 
Female 1 Jack Russell Terrier Bilateral Test ABD 
Vulva  
Enlarged clitoris with bone 
Increased anogenital distance 
compared to normal females 
Uterus 
No other information 
- [18] 
Female 1 
English Cocker 
Spaniel 
Bilateral Test ABD 
Vulva; Enlarged clitoris with 
bone 
Epididymides not found 
Uterus 
- [19] 
Female 1 Beagle Bilateral Test ABD 
Vulva; Enlarged clitoris with 
bone 
Uterus 
Epididymides or vas 
deferens not found 
Dysuria 
Androgen levels 
under reference 
range for male 
dogs 
[20] 
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Female 1 
American 
Staffordshire 
Terrier 
Bilateral Test ABD 
Vulva; Enlarged clitoris with 
bone 
Small uterus - [21] 
Female 1 Whoodle 
Ovot  
[previous 
unilateral 
gonadectomy] 
ABD Vulva  Gonad with CL 
Estrus behavior 
and enlarged 
mammary glands 
Increased blood 
progesterone 
[22] 
 
Female 2 
Cocker Spaniel 
[English] 
Bilateral Ovot  ABD 
Vulva; Enlarged clitoris with 
bone 
Ovarian bursa  
Oviducts 
Epididymides and vas 
deferens 
Uterus 
Anestrus 
Male-like behavior 
[23] 
PitBull cross 
Anestrus 
Occasional male 
attraction, 
mammary 
hypertrophy and 
milk ejection 
Increased blood 
progesterone 
Female 2 
Norwegian 
Elkhounds 
Bilateral Ovot  ABD 
Vulva; Enlarged clitoris with 
bone 
Uterus and vagina 
Epididymides and vas 
deferens not found 
 
[24] 
Bilateral Test ABD 
Uterus and vagina 
Epididymides and vas 
deferens  
 
Female 1 Basset Hound Bilateral Ovot ABD 
Vulva; Enlarged clitoris with 
bone 
Oviducts 
Epididymides  
Uterus 
Shortened vagina 
Mucopurulent 
vaginal discharge 
[25] 
OBM Genetics 2019; 3(2), doi:10.21926/obm.genet.1902074 
 
Page 6/21 
Male  
2 
English Cocker 
Spaniel  
Test + Ovot 
ABD 
Hypoplastic penis 
Preputium caudally dislocated  
Penile hypospadias 
Absence of scrotum 
Bilateral cryptorchidism  
Unilateral ovarian bursa 
[Ovot] 
Epididymis [Test] 
Uterus 
- [9] 
Female Bilateral Ovot 
Vulva 
Enlarged clitoris with bone 
No scrotum 
Ovarian bursa  
Oviducts 
Rudimentary epididymides 
and vas deferens 
Uterus 
Female 2 Pitbull Beagle Bilateral Test ABD 
Vulva Enlarged clitoris with 
bone 
Epididymis  
Uterus 
- 
[26] 
 
Female 1 Mongrel Bilateral Test ABD 
Vulva Enlarged clitoris with 
bone 
Oviducts not found 
Rudimentary epididymides 
Uterus 
Testosterone 
levels within 
normal range for 
male dogs 
[27] 
Female 5 
Basset Hound 
Soft coated 
Wheaten terrier 
Bilateral Ovot 
ABD 
Vulva Enlarged clitoris with 
bone 
Not provided - [28] Beagle 
Walker Hound 
Bilateral Test 
Doberman Ov + Ovot 
Not 
mentioned 
12 
American 
Staffordshire 
Terrier [2] 
Pug [1] 
Cocker spaniel 
Bilateral Test  ABD Not provided Not provided - [29] 
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[English] [1] 
French Bulldog [2] 
Leonberg [1] 
Cocker Spaniel 
[English] [2] 
Beagle [1] 
Bilateral Ovot 
Bernaise Mountain 
dog [1] 
Ovot+Test 
French Bulldog [1] 
Test 
+neoplastic 
gonad  
Not 
mentioned 
4 
Cocker spaniel 
[English]  
American 
Staffordshire 
Terrier 
Bilateral Test 
ABD Not provided Not provided - 
[30] 
 
Beagle 
Cane Corso 
Bilateral Ovot 
Ovot-ovotestis; Test-testicle(s); Ov–ovary; ABD–abdominal; ING–inguinal; SCr–scrotal; SC–subcutaneous
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Figure 1 The morphology of the gonad in XX;SRY-negative dogs resembles that of a 
male (ovoid, compact structure) in intra-abdominal location. A. The gonad is often 
located within the ovarian bursa, which supports the oviduct (Ovi); the epididymis (Ep) 
usually runs parallel to the gonad. The ostium of the ovarian bursa may be found on 
the medial face. B. The mediastinum testis (MT) usually found in the centre of the 
longitudinal sections of a normal testicle (on the left) is not perceived in the XX;SRY-
negative gonad (at the middle and right in the bottom image). 
Histological analysis of the gonads usually reveals a predominance of testis-like structures. 
Sertoli cells-only seminiferous tubules are often found, but sporadic degenerative spermatogonia 
and rare leptotene may also be observed [9]. However, the absence of germ cell stratification is 
the rule. In the interstitium, it is often observed an increase in the density Leydig cells [9], which 
often show a more eosinophilic cytoplasm, suggesting its immaturity. Similar features are found in 
Leydig cells in intra-abdominal cryptorchid testis in dogs (Payan-Carreira, unpublished). This 
parenchyma represents the totality of the gonad in the testicular type of gonads, or occupies a 
large medullary zone of the gonadal tissue, in the case of ovotestis. In either the ovotestis or 
testicular sub-type of XX;SRY-negative gonads, irregular lobulation may be found (Figure 2), 
originating from bundles of connective tissue that originate from the albuginea [31], a dense 
capsule of connective tissue delimiting the testis. If an ovotestis exists, the continuity of the 
albuginea is interrupted by the presence of an epithelial layer similar to the surface epithelium 
found in the dog ovary (Figure 2). Under the area of the surface epithelium, follicles in different 
stages, some displaying signs of atresia, may be evidenced in cortical position [7, 8]. Most 
frequently, they are primordial and primary follicles but, in some cases, they might reach the 
antral stage and be endocrinally active. Nonetheless, the density of the follicles in the cortical 
stroma is lower than the usual for the normal ovary (Payan-Carreira, unpublished), and therefore 
the connective tissue predominates.  
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Figure 2 Microscopic images of XX;SRY-negative gonads (hematoxylin-eosin staining). 
In the ovotesticular sub-type, scant follicles are found scattered in the cortex 
presenting a dense ovarian-like stroma. A Germ cells are surrounded by a single layer 
of flat or cuboid granulosa cells (100x). B. In the areas presenting follicles, the 
existence of a structure resembling the surface epithelia may be found (200x). C. In 
smaller magnification the existence of testicular lobules may be perceived, the septa 
originating from the dense albuginea cover typical of the testis (40x). D. Some 
disorganization may also be found among the gonadal lobules, with some of the 
lobules presenting a small number of seminiferous tubules and a predominance of 
interstitial elements (200x). E. In general, large eosinophilic Leydig cells are observed in 
testicular or ovotesticular DSD gonads (200x). F. The seminiferous tubules comprise 
mainly Sertoli cells and often are devoid of germinal epithelium; the lumen is also 
often absent (400x). 
In general, XX;SRY-negative dogs are bilateral cryptorchid, and their phenotype displays a 
variable degree of masculinization. Most commonly, dogs present a vulva and a hyperplastic 
clitoris (Figure 3) although they might also present a rudimentary penis within a shortened 
preputium (Figure 3) [31], opening closer to the anus [8, 31] and hypospadias (urethra opening in 
the underside of the penis). The examination of the enlarged clitoris reveals the existence of an 
undeveloped baculum, whose existence may be confirmed by ultrasound scanning and X-rays in 
lateral recumbency (Figure 4). 
In either case, the scrotum is usually absent, and the gonads are in an intra-abdominal location. 
In the transrectal evaluation, the prostate is generally absent  whether in animals with a female or 
a male phenotype [31]. Meyers-Wallen [8] mentions that in the American Cocker, the phenotype 
of a vulva with a protruding clitoris is observed in 15% of the cases; but in other breeds, that 
phenotype seems to be described more frequently than the more masculinized one, where a short 
prepuce and penis are present (Table 1; Figure 3). 
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Figure 3 The external genitalia of XX;SRY-negative dogs may show two main patterns: a 
female type (A and B) with a vulva placed in ventral position and an enlarged clitoris 
exposed from the vulva; and a more virilized, male-like type (C), showing a prepuce, 
usually shorten than in normal males, but without development of the scrotum. The 
animal is usually a bilateral cryptorchid. 
 
Figure 4 (A) The ultrasound examination of the vulvar area shows the presence of a residual 
baculum () within a structure resembling a rudimentary penis (*), surrounded by thick skin 
folders (arrow). (B) On the X-ray, the presence of the baculum can also be perceived (within 
the yellow circle). 
In dogs presenting a male-like phenotype, the ostium of the prepuce does not display its usual 
appearance, but rather resembles the vulvar folders of females (Figure 3C), with the preputial 
ostium in an eccentric position. Nonetheless, in dogs with a female phenotype, the vagina 
terminates shortly in a cul-de-sac. The exploitation of the short sized vaginal cavity is often difficult. 
A vaginal cytology can be obtained. It is useful to confirm the inability to progress the swab 
through the vaginal vault, and typically presents the features of a male preputial cytology (Figure 
5). 
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Figure 5 Vaginal cytology from a XX;SRY-negative dog with a female like phenotype, 
showing the presence of a large round epithelial cells and a considerable number of 
neutrophils (Diff-Quick® staining; 200x). 
2. A Short Overview of the Gonadal Differentiation in Embryos 
2.1. The Determination of the Normal Gonadal Pattern 
Precursor cells of gonads originate from the urogenital ridges, which are morphologically 
identical in XX and XY embryos [34]. First, a bipotential gonad is formed, congregating cells of 
mesodermal origin, which will be permeated by primordial germ cells. The differentiation of the 
different gonadal cell lineages (supporting and steroidogenic cells, and peritubular and stromal 
cells) during the differentiation of the bipotential gonad towards a male or female fate does not 
need the presence of germ cells [35]. 
The establishment of a gonadal gender takes place from the same bipotential gonad, 
depending on the pathway that is activated from the genetic background of the embryo, which is 
determined at fertilization [36]: 78,XY for male dogs and 78,XX for female dogs. The differentiation 
of the bipotential gonad towards of the male pathway occurs earlier than the differentiation of 
the ovary, which was thought to be the default pathway. The differentiation and development of 
the sexual duct system and the phenotypic sex is subsequent to the establishment of the gonadal 
sex, and commanded by the gender of the differentiated gonad [36, 37], as it is directed by 
hormones produced by the differentiated gonad through distinctive local signaling pathways. 
Testicular differentiation starts after the entrance of the primordial germ cells in the gonads, 
and it is coordinated by one cell type [38]. The transition from the undifferentiated rudiment into 
a male or female gonad is determined by the expression of SRY, a sex determining gene located in 
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the Y-chromosome [39, 40]. It has been proposed that several genes are required for the 
development of the bipotential gonad, such as NR5A1, WT1, GATA4 and FOG2, and may be 
involved in SRY transcription [41]. SRY transcription is limited in time and space [38, 39, 42], but it 
presents multiple and prolonged effects during the differentiation of the male gonad due to the 
activation of multilayered downstream pathways. SRY expression begins in the centre of the 
gonad, spreading towards the pole in a wave, paracrine fashion [34, 43, 44]. Of note, in the 
bipotential gonad, both the male and female determining genes are expressed at similar levels 
[40]. These genes are up-or down-regulated during the gonadal differentiation as an answer to the 
signaling of gender-driven genes. This is an important aspect to retain, as it would explain most 
features of dysplastic gonads in DSD conditions.  
The most important gene activated by SRY is SOX9. This gene is necessary and sufficient to 
induce testicular differentiation [39, 45]. SOX9 is necessary for the differentiation of Sertoli cells 
from precursor mesonephric cells, and for the maintenance of the differentiated phenotype, as 
well as for directing the development of the other somatic testicular cell lineages [12, 39, 40, 42, 
46]. Therefore, Sertoli cells act as organizing centers for the diverse morphological 
transformations that culminate with the formation of testicles [38, 44]. After an initial up-
regulation in SOX9 expression, SOX9 is maintained at high levels in Sertoli cells by FGF9 (Fibroblast 
growth factor gene) signaling, in a feed-forward loop [35] that no longer requires SRY expression 
[38]. NR5A1 [or SF1, Steroidogenic Factor-1), which along with WT1 (Wilms tumor 1) plays a 
crucial role in the formation of the bipotential gonad, also acts as a SRY-mediated SOX9 enhancer 
through testis differentiation [35, 47]. In some species, like in mice, humans, and dogs, a testis-
specific enhancer motif (termed Tesco, RevSex and CanRevSex, respectively) has been 
demonstrated to mediate SRY and Nr5a1 synergic interaction [48] to enhance the transactivation 
of SOX9 by multiple folds [41]. Additional contributions of other genes from the SOX family [e.g., 
SOX3 and SOX10) has also been evidenced [41, 49] from the study of DSD conditions. 
Acting through its receptor (FGFR2), Fgf9 suppresses the Wnt4 signaling pathway, inhibiting the 
mechanism that controls the ovarian differentiation [40, 44, 45, 50]. Moreover, Fgf9 sustains SOX9 
expression through a positive feedback loop [34]. It is also associated with the testis cord 
formation, which depends primarily on the Sertoli-Sertoli cell interaction, and is not driven by 
germ cells [34]. Fgf9 also suppresses meiosis in primordial germ cells, by impairing the rise in 
retinoic acid in the differentiating male gonads [51]. Cord formation is closely followed by the 
development of a vascular network from migrating endothelial cells, following a male-type pattern 
[34, 52] where the more prominent vessels locate at the periphery of the gonad, emitting small 
branches between the testis cords [53], as well as by the formation of the testicular albuginea [34]. 
Among other environmental autonomous gonadal signals, prostaglandin D2 promotes SOX9 
expression in neighboring cells, thereby being able to recruit somatic precursors cells to the Sertoli 
cell fate, even in the absence of SRY [40, 44]. This fact may represent an amplification mechanism 
aiming to ensure the minimum threshold number of differentiated Sertoli cells needed for 
testicular development [40] since SOX9 expression stimulates Pgd2 levels in the differentiating 
gonad [34]. 
The ovary differentiation occurs sometime after the moment of male gonadal differentiation 
[40], albeit the female-specific genes are transcribed earlier [54]. For long considered as a default 
process, its mechanism remains less clear than that of the embryonic testicular differentiation. 
Downregulation of genes associated with the male pathway in XX gonads is crucial to the 
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commitment to the female fate [49]. In the absence of SRY gene, and consequently in the absence 
of SOX9 signaling, the canonical WNT signaling pathways are activated in the somatic cell of the 
gonads [44], a critical step in the ovary differentiation. In response to Wnt4, the vascularization of 
the gonad takes a typical female pattern, and the somatic cells differentiate as granulosa and 
stromal cells. 
WNT4 (Wingless-type MMTV integration site 4) requires several co-activators to prompt the 
ovarian differentiation, the RSPO1 (R-spondin ligand 1) representing an important molecule of the 
canonical Wnt signaling cascade [35, 45]. The activation of the Wnt4 signaling cascade leads to the 
accumulation of -catenin, which becomes available to translocate to the nucleus and trigger 
diverse transcriptional factors [50]. The stabilization of -catenin exerts a positive feedback over 
WNT4 expression, with RSPO1 serving as a cofactor. All three genes cooperate to support the 
gonadal differentiation towards an ovarian fate. In female embryos, activation of the WNT4 gene 
is accompanied by the expression of RSPO1. The precursors of somatic cells respond to an 
increase in Rspo1/Wnt4 signaling by accumulating -catenin [37, 40, 50] and down-regulating 
SOX9 expression [55]. Loss of function studies in female mice embryos showed the development 
of a rounded male-like gonad, containing androgen-producing cells and the loss of female germ 
cells. It has been shown that Wnt4 promotes germ cell survival [50]. Wnt4/Rspon1/-catenin 
pathway also regulates the prolonged proliferation of the cortical region, originating the constant 
recruitment of granulosa cell precursors [56]. Furthermore, Wnt4 and Rspo1 are required to 
maintain the precursors of the granulosa cells in an undifferentiated status until birth [47]. 
It has been proposed that the loss of another determining ovarian differentiation gene–FOXL2 
(Forkhead Box L2) [37, 45]-may originate an up-regulation of the pro-testis pathway mediated by 
SOX9 [57], and the transdifferentiation of granulosa cells into Sertoli cells in the adult mouse ovary 
[58]. The FOXL2 pathway, however, seems to be independent of the WNT signaling cascade, albeit 
with the same aim–orchestrate the ovary differentiation. Foxl2 is crucial for granulosa cell 
differentiation and the maintenance of an ovary structure [53]. Stabilization of the granulosa cell 
differentiation, and therefore of the ovarian differentiation, is further promoted by germ cell 
commitment to meiosis [49], which in turn is driven by the expression of STRA8, whose expression 
is dependent of retinoic acid [56, 59].  
Since the response to the loss of Foxl2 signaling seems to vary between species, and also with 
the moment of occurrence, it has been suggested that it may be more important for the 
maintenance of the female gonad structure than to its differentiation from the bipotential gonad 
[35, 60]. Disturbed expression of Foxl2 has been associated with ovarian dysgenesis, blockage of 
follicle formation and disruption of follicle activation in human and mice, besides the ovary-to-
testis sex reversal in some species such as goats [45, 50, 57]. Species differences regarding the 
moment of gonadal female-to-male sex reversal may relate to the physiologic ability for estrogen 
secretion by the fetal gonads. Therefore, the loss of the ovarian identity in mice occurs in the 
postnatal ovary, while in polled DSD goats it is established in the fetal gonads [60]. Estrogen up-
regulate FOXL2 expression [61]. The loss of FOXL2 function leads to the loss of aromatase 
expression and the inability to secrete estrogen, along with an up-regulation of SOX9 transcription 
and subsequent differentiation of Sertoli cells and AMH (Anti-Müllerian Hormone) expression [61]. 
From the above mentioned it could be suggested that estrogen acts as part of the environmental 
factors shaping the fate of the developing gonad into an ovary in synergy with FOXL2. 
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2.2. What Might Go Wrong in the Ovarian Development in 78,XX;SRY-Negative Dogs  
In the bipotential gonad, both the male-determining genes (SOX9 and FGF9, for the testis fate, 
and WNT4 and RSPO1, for the ovary fate) are expressed at similar levels [40, 45]. At the moment 
of gonadal differentiation, SOX9 expression is raised in male embryos, but maintained in residual 
levels in females [45]. Since the precursor cell types are similar in the bipotential gonads of both 
female and male embryos [43], once the fate of the supporting cells is established, it orchestrates 
the differentiation of all other cell lineages in the gonad [49]. 
Considering that the ovarian-determining pathway actively suppresses the testis-determining 
pathway [38], one could suspect that, in the case of female-to-male sex reversal, a disruption of 
the female-determining genes would occur, which in turn would allow the activation of the male-
determining genes, even in the absence of SRY transcription. In some species, it has been 
demonstrated that the loss of function of Rspo1, Foxl2 and estrogen receptor alpha will activate 
the male-determining pathway, upregulating SOX9 [38]. It has also been shown that in the 
absence of Wnt4, the transcription of FGF9 is upregulated [38]. 
The multi-layered input into sex determination [40], with multiple signaling cascades 
determining the fate of the embryonic gonad between the male and a female pattern, makes it 
difficult to identify the mechanism underlying the XX;SRY-negative syndrome, as well as the range 
of abnormalities described in the gonads of affected animals. The commitment of the precursor 
somatic cells of bipotential gonads toward a male or female fate drives the gonadal differentiation 
in the fetus [41]. The differentiation of Sertoli cells early in the process will, therefore, constrain 
the pattern of the differentiating gonad.  
The development of a gonad into a testicular or an ovotesticular pattern may represent 
different degrees of the same process, because ovotestis and testicular types may co-exist in the 
same animal. Moreover, the centre-to-pole temporal profile in the differentiation of Sertoli cells 
[44] may contribute to imbalances in the propagation of the differentiation wave, allowing the 
two types of arrangement to develop. Meyers-Wallen proposed that, at least in the familiar 
American Cocker DSD syndrome, the phenotypic variability is probably related to threshold effects 
[8]. 
In the case of canine SRY-negative DSD, the mechanism responsible for the presence of 
testicular tissue remains unclear. Species-specific differences resulting from the process and the 
time-lapse of the gonad differentiation might be responsible for the divergence of phenotypes 
described in XX;SRY-negative sex reversal, both amongst and within a species. It can also result 
from the disruption of distinct genetic pathways. Therefore, from this point on, this review will 
focus mainly on the studies regarding the etiopathogenesis of canine XX;SRY-negative conditions.    
2.1.1 Loss of Function of NR5A1 
Mutation in the NR5A1 gene, causing loss of function [62], has been associated with primary 
ovarian insufficiency in women and with OT-DSD/T-DSD development in 46;XX individuals [41, 63]. 
It has been recently proposed that NR5A1 should be used to promote proliferation of gonadal 
somatic cells. The exact mechanism underlying this effect is not clear. Since NR5A1 coordinates 
the ability for steroidogenic synthesis, it is possible that this role in XX;SRY-negative DSD 
pathogenesis may not be only related with direct disruption of the ovary-specific pathways [64], 
but also to the control of cytochrome P450 steroid hydroxylase enzymes [65] and the ability to 
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create an estrogen-dominant environment, which has been shown to be determinant of an ovary-
fate. In humans, loss of NR5A1 function is also accompanied by hypospadias, a condition also 
found in some cases of XX;SRY-negative dogs. Moreover, the persistence of Mullerian-derived 
structures, like the oviducts and the uterus, would also be supported by an impairment of the 
NR5A1 cascade, as this gene is a transcriptional regulator of the Anti-Mullerian Hormone [66], 
which secretion has been shown to be delayed in of XX;SRY-negative dogs [8]. However, the few 
genetic and pedigree studies developed in XX;SRY-negative DSD in dogs considered NR5A1 unlikely 
to be a causative gene for this condition in the species [8, 66]. 
2.2.2 Loss of Function of Wnt4/Rspon1/-Catenin and Foxl2 Pathways 
On respect to WNT4 and RSPO1 loss-of-function, a premature differentiation of granulosa cells 
will occur, and the subsequent transdifferentiation of these cells and impaired oogonial 
differentiation or entering meiosis [47]. Any malfunctioning on the Wnt4/Rspon1/-Catenin 
pathway would reflect in a failure to downregulate SOX9 transcription, thus potentially supporting 
the differentiation of a male-like gonad. In addition, since Wnt also supports Follistatin expression, 
a loss of function of WNT4 transcription would also explain the reduced number of follicles and 
oocytes found in the ovotestis sub-type DSD. Besides, as such loss of function would also enhance 
testosterone synthesis, the increased secretion of androgens could explain the partial 
masculinization of genital ducts, and the development of epididymides and deferens ducts in  
XX;SRY-negative individuals [67]. Studies on the methylation of WNT4 gene showed that 
methylation was similar in XX DSD and control dogs [30], suggesting that this may not be an 
adequate candidate gene for the XX DSD syndrome in dogs. Still, a decreased transcription of 
WNT4 was reported in XX DSD embryos using a genome wide association study and whole 
genome sequencing [13]. The same study describes a decrease in RSPO1 and FOXL2 expression, 
demonstrating that the ovary determining genes are downregulated in canine gonads from 
embryos at risk of XX DSD, while the testicular determining genes (namely the SOX9 and FGF9) are 
up-regulated [13]. 
Even though the participation of FOXL2 reported in the pathogen of sex reversal conditions in 
some species, like the goat, supported its study as a candidate gene for canine ovotesticular DSD, 
it has been demonstrated that FOXL2 is not responsible for the canine disorder [1, 66]. A similar 
conclusion was drawn regarding the participation of the -catenin gene [1]. 
2.2.3 Gain of Function of SOX9 
Expression of SOX9 was found to be increased in the absence of SRY, thanks to the participation 
of different activators [49]. A SOX9 enhancer was identified upstream of the SOX9 transcription 
start site, which is a target to steroidogenic factor 1 (SF1) and SRY [68]. As these enhancers usually 
participate in an autoregulatory loop, they sustain each other's expression through time. 
Mutations of this enhancer may be responsible for abolishing the need for SRY activation and 
consequently to the gain of function of the SOX9 signaling cascade.  
Albeit a duplication of the SOX9 coding region has been found in two dogs diagnosed as  
XX;SRY-negative [69], some studies demonstrated that other individuals do not present SOX9 
duplication [21, 70]. Conversely, duplication [15] or copy variations [13] of a region upstream of 
the SOX9 gene have been identified in XX;SRY-negative dogs. Two highly polymorphic copy 
OBM Genetics 2019; 3(2), doi:10.21926/obm.genet.1902074 
 
Page 16/21 
number variable regions have been identified in upstream regions to the canine SOX9 gene; one of 
those being at a similar distance from the SOX9 as that of the human RevSex [29]. One of these 
regions likely contains an enhancer region for SOX9 [13, 70], whose duplication may induce the 
SOX9 expression in the absence of SRY [29].  
Recently, significantly higher methylation of SOX3 gene [30] has been reported in both the 
ovotesticular and the testicular canine XX DSD. In mice, it has been shown that SOX3 can replace 
SRY and drive the differentiating gonad towards a female fate [63]. 
3. Final Considerations 
Despite all of the progress made through the years on the elimination of canine XX;SRY-
negative candidate genes, the molecular mechanisms involved in the etiopathogenesis of canine 
XX DSD remain poorly characterized. The mechanisms orchestrating the ovary-to-testicular or 
ovotesticular reversal in the absence of SRY remain elusive, not only in dogs but also in other 
species. The existence of a wide variety of phenotypes only adds to the difficulties in finding an 
explanation. For that, the histopathological examination of the gonads of animals with DSD is very 
important and supplementary to cytogenetic tests. Albeit a large number of reports exist in canine 
sex reversal, some descriptions of the clinical conditions are not supported by adequate 
karyotyping and cytogenetic analyses, thus representing pure diagnostic speculations. Also, it 
would be important to obtain sex hormone profiles from animals suffering from this condition to 
support clinical findings, in particular in respect to the production of androgens and the ability to 
convert testosterone to dihydrotestosterone. Recent studies focus now on the up-regulation of 
SOX9 transcription in the absence of SRY, in particular on the gain-of-function of SOX9 enhancer 
regions, as well as on the eventual participation of other SOX genes, e.g. the SOX3. The use of 
larger cohorts of individuals, either purebreds, mongrels or crosses, would be helpful to validate 
the participation of those candidate genes and to confirm the genetic transmission of the disease. 
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